Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2006 2
2007 1
2008 1
2009 1
2010 1
2011 4
2012 8
2013 7
2014 11
2015 9
2016 6
2017 11
2018 8
2019 11
2020 5
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Endothelial cell senescence in aging-related vascular dysfunction.
Jia G, Aroor AR, Jia C, Sowers JR. Jia G, et al. Among authors: aroor ar. Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1802-1809. doi: 10.1016/j.bbadis.2018.08.008. Epub 2018 Aug 18. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 31109450 Free article. Review.
The pathophysiology of hypertension in patients with obesity.
DeMarco VG, Aroor AR, Sowers JR. DeMarco VG, et al. Among authors: aroor ar. Nat Rev Endocrinol. 2014 Jun;10(6):364-76. doi: 10.1038/nrendo.2014.44. Epub 2014 Apr 15. Nat Rev Endocrinol. 2014. PMID: 24732974 Free PMC article. Review.
Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.
Das NA, Carpenter AJ, Belenchia A, Aroor AR, Noda M, Siebenlist U, Chandrasekar B, DeMarco VG. Das NA, et al. Among authors: aroor ar. Cell Signal. 2020 Apr;68:109506. doi: 10.1016/j.cellsig.2019.109506. Epub 2019 Dec 17. Cell Signal. 2020. PMID: 31862399 Free PMC article.
The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.
Sukhanov S, Higashi Y, Yoshida T, Mummidi S, Aroor AR, Jeffrey Russell J, Bender SB, DeMarco VG, Chandrasekar B. Sukhanov S, et al. Among authors: aroor ar. Cell Signal. 2021 Jan;77:109825. doi: 10.1016/j.cellsig.2020.109825. Epub 2020 Nov 4. Cell Signal. 2021. PMID: 33160017
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Aroor AR, Das NA, Carpenter AJ, Habibi J, Jia G, Ramirez-Perez FI, Martinez-Lemus L, Manrique-Acevedo CM, Hayden MR, Duta C, Nistala R, Mayoux E, Padilla J, Chandrasekar B, DeMarco VG. Aroor AR, et al. Cardiovasc Diabetol. 2018 Jul 30;17(1):108. doi: 10.1186/s12933-018-0750-8. Cardiovasc Diabetol. 2018. PMID: 30060748 Free PMC article.
Cellular mechanisms underlying obesity-induced arterial stiffness.
Aroor AR, Jia G, Sowers JR. Aroor AR, et al. Am J Physiol Regul Integr Comp Physiol. 2018 Mar 1;314(3):R387-R398. doi: 10.1152/ajpregu.00235.2016. Epub 2017 Nov 22. Am J Physiol Regul Integr Comp Physiol. 2018. PMID: 29167167 Free PMC article. Review.
Vascular stiffness in insulin resistance and obesity.
Jia G, Aroor AR, DeMarco VG, Martinez-Lemus LA, Meininger GA, Sowers JR. Jia G, et al. Among authors: aroor ar. Front Physiol. 2015 Aug 14;6:231. doi: 10.3389/fphys.2015.00231. eCollection 2015. Front Physiol. 2015. PMID: 26321962 Free PMC article. Review.
Overnutrition, mTOR signaling, and cardiovascular diseases.
Jia G, Aroor AR, Martinez-Lemus LA, Sowers JR. Jia G, et al. Among authors: aroor ar. Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1198-206. doi: 10.1152/ajpregu.00262.2014. Epub 2014 Sep 24. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 25253086 Free PMC article. Review.
81 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page